Two Sigma Investments’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-170,900
Closed -$2.01M 4809
2025
Q4
$2.01M Buy
+170,900
New +$1.84M ﹤0.01% 2424
2024
Q2
Sell
-32,500
Closed -$511K 3221
2024
Q1
$511K Sell
32,500
-12,400
-28% -$191K ﹤0.01% 2325
2023
Q4
$726K Sell
44,900
-54
-0.1% -$884 ﹤0.01% 2258
2023
Q3
$553K Sell
44,954
-70,889
-61% -$1.05M ﹤0.01% 2233
2023
Q2
$1.86M Buy
115,843
+1,243
+1% +$20.5K ﹤0.01% 1479
2023
Q1
$2M Sell
114,600
-156,400
-58% -$2.23M 0.01% 1383
2022
Q4
$2.5M Sell
271,000
-406,199
-60% -$3.79M 0.01% 1205
2022
Q3
$5.83M Sell
677,199
-782,858
-54% -$7.77M 0.02% 693
2022
Q2
$11.9M Buy
1,460,057
+604,070
+71% +$5.77M 0.04% 455
2022
Q1
$10.4M Buy
+855,987
New +$18M 0.03% 596
2019
Q2
Sell
-73,821
Closed -$1.51M 3549
2019
Q1
$1.51M Sell
73,821
-513,846
-87% -$8.93M ﹤0.01% 1577
2018
Q4
$7.41M Sell
587,667
-14,599
-2% -$218K 0.03% 634
2018
Q3
$9.24M Buy
602,266
+337,645
+128% +$4.67M 0.03% 672
2018
Q2
$3.47M Buy
+264,621
New +$2.91M 0.01% 1241
2016
Q3
Sell
-163,823
Closed -$1.32M 3291
2016
Q2
$1.32M Buy
163,823
+130,419
+390% +$1.05M 0.01% 1548
2016
Q1
$225K Sell
33,404
-46,288
-58% -$305K ﹤0.01% 2531
2015
Q4
$627K Buy
+79,692
New +$584K ﹤0.01% 1825
2015
Q1
Sell
-58,636
Closed -$245K 2773
2014
Q4
$245K Sell
58,636
-13,973
-19% -$64.2K ﹤0.01% 1992
2014
Q3
$378K Buy
+72,609
New +$373K ﹤0.01% 1391

Other funds holding NEO

Two Sigma Investments's NEO Position: Q1 2026 in Review

Two Sigma Investments sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 170,900 shares — an estimated $2.01M sold.

Two Sigma Investments first reported a position in NEO in Q3 2014 and held it in 19 quarters. The position peaked at $11.9M in Q2 2022. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Two Sigma Investments reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 170,900 NeoGenomics shares in Q1 2026, an estimated $2.01M.
  • Two Sigma Investments first reported a position in NeoGenomics in Q3 2014 and held it in 19 quarters.
  • Two Sigma Investments's NeoGenomics position peaked at $11.9M in Q2 2022.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.